Covered recipient · General Payments record
MANISH SHARMA
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$4,804.28
- Reported across 129 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $525.00 | 1 |
| Food and Beverage | $248.90 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Aadi Bioscience, Inc. | $525.00 | 1 |
| Theratechnologies Inc. | $96.27 | 1 |
| PFIZER INC. | $38.64 | 3 |
| Incyte Corporation | $35.80 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $31.48 | 1 |
| ABBVIE INC. | $16.32 | 1 |
| EMD Serono, Inc. | $16.29 | 1 |
| Astellas Pharma US Inc | $14.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aadi Bioscience, Inc. | $525.00 | 08/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1119596799 | CMS |
| ABBVIE INC. | $16.32 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106075368 | CMS |
| Astellas Pharma US Inc | $14.10 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139281138 | CMS |
| EMD Serono, Inc. | $16.29 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120244105 | CMS |
| Incyte Corporation | $16.38 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141304779 | CMS |
| Incyte Corporation | $19.42 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141322117 | CMS |
| Novartis Pharmaceuticals Corporation | $31.48 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087284499 | CMS |
| PFIZER INC. | $18.35 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131899297 | CMS |
| PFIZER INC. | $18.33 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131899623 | CMS |
| PFIZER INC. | $1.96 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131378733 | CMS |
| Theratechnologies Inc. | $96.27 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092906593 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.